Posts

Posted on

OTTAWA BANCORP, INC. ANNOUNCES CASH DIVIDEND

OTTAWA, Ill., Nov. 18, 2020 (GLOBE NEWSWIRE) —  Ottawa Bancorp, Inc. (OTCQX: OTTW), the holding company for Ottawa Savings Bank FSB, announced today that its Board of Directors has declared a quarterly cash dividend of $0.08 per share, payable on or about December 16, 2020, to stockholders of record as of the close of business on December 2, 2020.    

Ottawa Bancorp, Inc. is the holding company for Ottawa Savings Bank, FSB which provides various financial services to individual and corporate customers in the United States. The Bank offers various deposit accounts, including checking, money market, regular savings, club savings, certificate, and various retirement accounts. Its loan portfolio includes one-to-four family residential mortgage, multi-family and non-residential real estate, commercial, and construction loans as well as auto loans and home equity lines of credit. Ottawa Savings Bank, FSB was founded in 1871 and is headquartered in Ottawa, Illinois. For more information about the Company and the Bank, please visit www.ottawasavings.com.



Contact:       Craig Hepner
               President and Chief Executive Officer
               (815) 366-5437

Posted on

Fusion Fuel Green plc and HL Acquisitions Corp. Announce Partnership with EREE Desarrollos Empresariales SL

New York, New York and Dublin, Ireland, Nov. 18, 2020 (GLOBE NEWSWIRE) — HL Acquisitions Corp (“HL”, NASDAQ: HCCH, HCCHU, HCCHR, HCCHW) and its business combination partner, Fusion Fuel Green plc (“Fusion Fuel”), jointly announced that Fusion Fuel  has entered into a partnership with EREE Desarrollos Empresariales SL (“EREE”) to deploy its innovative micro-electrolyzer technology for producing green hydrogen.

EREE’s partners, Ignacio Esteve, Javier Esteban and Grant Greatrex, have extensive commercial experience in Spain as developers of large-scale solar projects, as well as waste-to-gas technology. The new joint venture, Fusion Fuel Spain, will be focused on developing and installing green hydrogen plants in Spain, using Fusion Fuel’s cost competitive green hydrogen solution.

Fusion Fuel has developed a disruptive micro-electrolyzer solution which, in conjunction with concentrated photovoltaic solar technology, will produce emissions-free green hydrogen at prices competitive with brown hydrogen. Fusion Fuel believes Spain is an ideal market for its technology due to the region’s high average annual solar resource, which will enable it to produce highly competitive green hydrogen.

The production and distribution of green hydrogen fits within the decarbonization targets identified by the European Commission. Conventional hydrogen production emits more than 9 tons of CO2 per ton of hydrogen, so transitioning to new methods of production is critically important to the reduction of carbon emissions. Green hydrogen has broad applications as an energy source for uses as varied as power generation, heavy-duty transport, and in industrial settings, and can be used to help decarbonize many highly energy- and carbon-intensive industries.

Spain recently announced its Green Hydrogen Strategy, in which it outlined targets of 4 GW of installed electrolyzer capacity and 4.6 million tons in carbon emissions reductions to be achieved by 2030. To kickstart the development of its hydrogen economy, Spain has already announced several large strategic green hydrogen projects and is rapidly ramping up investment in its hydrogen infrastructure.

EREE’s Partner, Javier Esteban, said “We see great potential to meet Spain’s green hydrogen objectives and believe Fusion Fuel’s technology is perfectly suited to leverage Spain’s excellent solar resource for delivering green hydrogen at a competitive price in the next few years.”

Fusion Fuel’s Head of Business Development, João Teixeira Wahnon added: “We are very excited to kick-off this exciting partnership. We see the Iberian Peninsula as having enormous potential for cost competitive green hydrogen and we believe this joint venture positions us to capitalize on the multitude of emerging commercial opportunities in Spain. Our aim is to develop a global footprint for Fusion Fuel and we see Spain as a natural first step in that expansion, following our initial foray in Portugal.” Mr. Wahnon continued: “We expect to use the capital being raised through our proposed business combination with HL Acquisitions Corp. and the associated private placement, in part, to execute on these commercial opportunities in Spain.”


Use of Social Media as a Source of Material News

Fusion Fuel intends to post a copy of the press release on its LinkedIn profile and/or its website (www.fusion-fuel.eu) and other social media outlets. Fusion Fuel uses, and will continue to use, its LinkedIn profile, website, press releases, and various social media channels, as additional means of disclosing information to investors, the media, and others interested in Fusion Fuel. It is possible that certain information that Fusion Fuel posts on social media or its website, or disseminates in press releases, could be deemed to be material information, and Fusion Fuel encourages investors, the media and others interested in Fusion Fuel to review the business and financial information that Fusion Fuel posts on its social media channels, website, and disseminates in press releases, as such information could be deemed to be material information.


No Offer or Solicitation

This communication is for informational purposes only and is neither an offer to sell or purchase, nor the solicitation of an offer to buy or sell any securities, nor is it a solicitation of any vote, consent, or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.

Forward looking statements

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Fusion Fuel’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statement, including, among other things, the occurrence of any event, change or other circumstance that could give rise to the termination of that certain Amended and Restated Business Combination Agreement, dated as of August 25, 2020, by and between HL Acquisitions Corp. (“HL”), Fusion Welcome – Fuel, S.A., Fusion Fuel, and the other parties thereto, changes adversely affecting the businesses in which Fusion Fuel is engaged, management of growth, general economic conditions, including changes in the credit, debit, securities, financial or capital markets, the impact of COVID-19 or other adverse public health developments on Fusion Fuel’s business and operations, and the other risks and uncertainties set forth in the definitive proxy statement/prospectus filed by Fusion Fuel on November 10, 2020. You are cautioned not to place undue reliance on these forward-looking statement, which speak only as of the date of this press release.

Additional Information and Where to Find It

HL and Fusion Fuel each filed a definitive proxy statement/prospectus with the SEC on November 10, 2020, and other relevant documents with the SEC. HL has commenced mailing the definitive proxy statement/prospectus to HL shareholders of record as of November 4, 2020. INVESTORS AND SECURITY HOLDERS OF HL ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND OTHER RELEVANT DOCUMENTS THAT HAVE BEEN FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain free copies of the proxy statement/prospectus and other documents containing important information about HL and Fusion Fuel through the website maintained by the SEC at http://www.sec.gov.

About EREE Partners

The three partners have extensive experience developing and operating solar energy and wind companies, with several GWs of capacity across Iberia and other countries. Their latest project includes the development of 300 MW of PV projects in Spain representing around €240m of investment. In addition, the team has experience in financing renewable projects in the PV, CSP, Wind, Biomass, W2E, Storage and associated sectors.

About Fusion Fuel

https://www.fusion-fuel.eu


Fusion Fuel is a Portuguese company that has developed a Green Hydrogen production technology that is expected to be a leader in the industry for generating cost-effective and competitively priced Green Hydrogen. Fusion Fuel’s vision is to become one of the core developers of Green Hydrogen technology in the coming years and to facilitate the transition to Green Hydrogen by providing a cost competitive alternative to Brown Hydrogen. The team has extensive experience in the renewable energy space and is in the process of seeking to complete a proposed business combination with HL Acquisitions Corp. (NASDAQ: HCCH).

Contact:

Frederico Figueira de Chaves
Director
Fusion Fuel Green plc
+351 960 439 641

Jeffrey E. Schwarz
Chief Executive Officer
HL Acquisitions Corp.
(212) 486-8100



Posted on

Making nourishing foods affordable and accessible for all

PR Newswire

BATTLE CREEK, Mich., Nov. 18, 2020 /PRNewswire/ — Nearly 30% of households in the United States earn less than $35,000 per year. After taxes, that equates to $2,625 in take home pay each month. There’s rent or mortgage to pay, utilities, car payments and, of course, groceries. But this was before the pandemic. COVID-19 has eliminated jobs and shrunken budgets. More families have been forced to make tough decisions at the end of every month, when budgets tend to be particularly limited. But that doesn’t have to be the case. Sarah Ludmer, Kellogg Company Senior Director of Wellbeing and Regulatory, shares how Kellogg is making nourishing foods affordable and accessible for all.


Social K – Kellogg Company Blog 
By Sarah Ludmer 
Kellogg Company Senior Director of Wellbeing and Regulatory

Kellogg’s portfolio is 86% plant based including cereals, snacks and veggie foods, which are often an affordable, accessible food option.

Our foods help promote the consumption of grains, fruits, vegetables, nuts, and legumes, which can help provide important nutrients like fiber, protein, vitamins and minerals. Kellogg’s cereals, for example, deliver important nutrients such as fiber, B vitamins and iron. Our plant-forward food can also be a driver of under-consumed food groups such as fruit, vegetables and dairy – think about a bowl of cereal that contains fruit, milk and cereal.

And our Morningstar Farms black bean burgers have 72 percent less fat than regular ground beef and deliver nine grams of protein. We’ve been making our veggie foods available broadly for 40 years through our Morningstar Farms brand and now with our new Incogmeato line of veggie burgers. 

When it comes to affordability, cereal especially serves as both an accessible and affordable meal option for families on a budget. Did you know that four servings of Kellogg cereal with milk and fruit costs less than $4? Several of our single serve snack foods also check in around the $1 price point, which a parent can use to nourish their child any time of day.

Our company knows it’s imperative to keep our food accessible to all communities.

In addition to donating millions of meals to food banks through our Better Days commitments, we engage with government stakeholders on a broad array of nutrition assistance programs that feed families in need.

We work with the U.S. Congress and Department of Agriculture to ensure that feeding programs meet the needs of our consumers. Specifically, we make food that qualifies for the Supplemental Nutrition Assistance Program (SNAP), which fed 35.7 million people in 2019, and the Special Supplemental Nutrition Program for Women, Infants & Children (WIC), which fed 6.4 million people in 2019. We also provide educational tools – such as delicious and simple recipes – to promote and support local WIC clinics to drive redemption of WIC dollars.

We are also closely engaged with and support programs that feed children nationwide, like the National School Lunch Program, School Breakfast Program, summer meals and more.

I am proud and motivated by the fact our company nourishes people with affordable and accessible foods and that we continue to play an important role in their overall wellbeing. To learn more, visit KelloggCompany.com.

About Kellogg Company
At Kellogg Company (NYSE: K), we strive to enrich and delight the world through foods and brands that matter. Our beloved brands include Pringles®, Cheez-It®, Special K®, Kellogg’s Frosted Flakes®, Pop-Tarts®, Kellogg’s Corn Flakes®, Rice Krispies®, Eggo®, Mini-Wheats®, Kashi®, RXBAR®, MorningStar Farms® and more. Net sales in 2019 were approximately $13.6 billion, comprised principally of snacks and convenience foods like cereal and frozen foods. Kellogg brands are beloved in markets around the world. We are also a company with Heart & Soul, committed to creating Better Days for 3 billion people by the end of 2030 through our Kellogg’s® Better Days global purpose platform. Visit www.KelloggCompany.com or www.OpenforBreakfast.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/making-nourishing-foods-affordable-and-accessible-for-all-301176462.html

SOURCE Kellogg Company

Posted on

Old Point Financial Corporation Declares Quarterly Dividend

PR Newswire

HAMPTON, Va., Nov. 18, 2020 /PRNewswire/ — Old Point Financial Corporation declared a quarterly cash dividend of $0.12 per share on its common stock to be paid on December 28, 2020 to shareholders of record as of December 2, 2020. The dividend amount is the same as the prior quarter’s dividend and based on the stock’s closing price of $16.51 on November 18, 2020, the dividend yield is approximately 2.9%. 

ABOUT OLD POINT FINANCIAL CORPORATION

Old Point Financial Corporation (Nasdaq: OPOF) is the parent company of Old Point National Bank, a locally owned and managed community bank, and Old Point Trust & Financial Services, N.A., a wealth management services provider, serving the Hampton Roads, Virginia region. Additional information on the Company is available at www.OldPoint.com under “Investor Relations”.

Contact:  Laura Wright, VP/Marketing Director, 757.728.1743

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/old-point-financial-corporation-declares-quarterly-dividend-301176495.html

SOURCE Old Point Financial Corporation

Posted on

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Akers Biosciences, Inc. – AKER

PR Newswire

NEW YORK, Nov. 18, 2020 /PRNewswire/ — Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Akers Biosciences, Inc. (“Akers” or the “Company”) (AKER) relating to its proposed merger into MyMD Pharmaceuticals. Under the terms of the agreement, Akers shareholders are expected to own only 20% of the combined company.

The investigation focuses on whether Akers Biosciences, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether and by how much this proposed transaction undervalues the Company.

Click here for more information:
 

https://www.monteverdelaw.com/case/akers-biosciences-inc

.
It is free and there is no cost or obligation to you.

About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders from corporate wrongdoing.  Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions.  Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field.  He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.  Our firm’s recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019).  Also, in 2019 we recovered money for shareholders in 6 mergers & acquisitions class action cases.

If you own common stock in Akers Biosciences, Inc. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde–associates-pc-announces-an-investigation-of-akers-biosciences-inc—aker-301176494.html

SOURCE Monteverde & Associates PC

Posted on

Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Conditional Redemption Of Additional Series Of Existing Senior Notes

PR Newswire

Following Redemptions, Bausch Health Will Have No Note Maturities Until 2024 

LAVAL, QC, Nov. 18, 2020 /PRNewswire/ — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) announced today that it has priced and upsized its previously announced offering of $1.0 billion aggregate principal amount of 5.000% senior notes due 2029 (the “2029 Notes”) and $1.0 billion aggregate principal amount of 5.250% senior notes due 2031 (the “2031 Notes” and, together with the 2029 Notes, the “Notes”). The size of the offering reflects an increase of $250 million from the previously announced offering size of $1.75 billion. The 2029 Notes will be sold to investors at a price of 100% of the principal amount thereof, and the 2031 Notes will be sold to investors at a price of 100% of the principal amount thereof.

The proceeds from the offering of the Notes, along with cash on hand, are expected to be used to fund the Company’s (i) previously announced conditional redemption (the “Euro Redemption”) in full of its outstanding €1.5 billion aggregate principal amount of 4.50% Senior Notes due 2023 (the “Euro Notes”) and (ii) conditional redemption (the “5.50% Redemption”) in full of its outstanding $233 million aggregate principal amount of 5.50% Senior Notes due 2023 (the “5.50% Notes” and, together with the Euro Notes, the “Existing Notes”), and to pay related fees and expenses. With these redemptions, Bausch Health will have no note maturities until 2024.

The Notes will be guaranteed by each of the Company’s subsidiaries that are guarantors under the Company’s credit agreement and existing senior notes. Consummation of the offering of the Notes is subject to various closing conditions.

The Notes will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities law and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act and applicable state securities laws. The Notes will be offered in the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and outside the United States to non-U.S. persons pursuant to Regulation S under the Securities Act. The Notes have not been and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the Notes in Canada will be made on a basis, which is exempt from the prospectus requirements of such securities laws.

This announcement does not constitute a notice of redemption with respect to the Existing Notes. The Euro Redemption is conditioned upon the completion by the Company or its subsidiaries of one or more debt financings in an aggregate principal amount of at least $1.75 billion, which the Company expects to satisfy upon closing of the offering of the Notes.

The Company also announced that it has issued today a conditional notice of redemption to redeem the full aggregate principal amount of outstanding 5.50% Notes. The 5.50% Redemption will be conditioned upon the completion by the Company or its subsidiaries of one or more debt financings in an aggregate principal amount of at least $2.0 billion (the “5.50% Condition”), which the Company expects to satisfy upon closing of the offering of the Notes.

A copy of the conditional notice of redemption with respect to the 5.50% Notes has been issued to the record holders of the 5.50% Notes. Payment of the redemption price and surrender of the 5.50% Notes for redemption will be made through the facilities of the Depository Trust Company in accordance with the applicable procedures of the Depository Trust Company on Dec. 18, 2020, unless the 5.50% Condition is not satisfied, in which case the redemption date will be delayed until the 5.50% Condition is satisfied. The name and address of the paying agent are as follows: The Bank of New York Mellon Trust Company, N.A., c/o The Bank of New York Mellon; 111 Sanders Creek Parkway, East Syracuse, N.Y. 13057; Attn: Redemption Unit; Tel: (800) 254- 2826.

This news release is being issued pursuant to Rule 135c under the Securities Act and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people’s lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.

Forward-looking Statements
This news release may contain forward-looking statements, including, but not limited to, our financing plans, including the offering of the Notes and the details thereof, including the proposed use of proceeds therefrom and other expected effects of the offering of the Notes. Forward-looking statements may generally be identified by the use of the words “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “believes,” “estimates,” “potential,” “target,” or “continue” and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, and the fear of that pandemic and its potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on the Company, including but not limited to its supply chain, third-party suppliers, project development timelines, employee base, liquidity, stock price, financial condition and costs (which may increase) and revenue and margins (both of which may decrease), other risks related to our business, including risks related to our pending legal and governmental proceedings, legislative and policy efforts, actions by the U.S. Food and Drug Administration and other regulators, our substantial debt, uncertainties associated with acquisitions and product launches, and risks and uncertainties discussed in our most recent annual and quarterly reports and detailed from time to time in our other filings with the Securities and Exchange Commission and the Canadian Securities Administrators, which risks and uncertainties are incorporated herein by reference. Management has also made certain assumptions in assessing the anticipated impacts of the COVID-19 pandemic on the Company and its results of operations and financial conditions, including: that there will be no material restrictions on access to health care products and services resulting from a possible resurgence of the virus on a global basis in the fourth quarter of 2020; that the strict social restrictions seen earlier this year will not be materially re-enacted in the event of a material resurgence of the virus; that there will be an ongoing gradual global recovery as the macroeconomic and health care impacts of the COVID-19 pandemic run their course; that the largest impact to the Company’s businesses were seen in the second quarter of 2020 although we expect additional COVID-19 pandemic related declines in the year-over-year revenues in the remainder of 2020 in many of our businesses and geographies; anticipate that our affected businesses could possibly return to pre-pandemic levels as early as late 2020 or in 2021, but that rates of recovery will vary by geography and business unit, with some regions and business units expected to lag in recovery possibly beyond 2021; and no major interruptions in the Company’s supply chain and distribution channels. If any of these assumptions regarding the impacts of the COVID-19 pandemic are incorrect, our actual results could differ materially from those described in these forward-looking statements. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. We undertake no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, except as required by law.


Investor Contact:


Media Contact:

Arthur Shannon

Lainie Keller


[email protected] 


[email protected]

(514) 856-3855

(908) 927-1198

(877) 281-6642 (toll free)

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bausch-health-announces-pricing-and-upsize-of-private-offering-of-senior-notes-and-conditional-redemption-of-additional-series-of-existing-senior-notes-301176493.html

SOURCE Bausch Health Companies Inc.

Posted on

Hanna Skandera Appointed President & CEO of the Daniels Fund

Denver, Colorado, Nov. 18, 2020 (GLOBE NEWSWIRE) — The Daniels Fund Board of Directors is delighted to announce that Hanna Skandera has been named the organization’s President & CEO effective December 15. Skandera will succeed Hank Brown, who has served as interim president & CEO since May 1.

Skandera has over two decades of executive leadership experience and a proven track record of impact in a variety of national and state-level private, public, and nonprofit organizations serving rural, suburban, and urban settings.

“It’s an honor to be selected as the next leader of Bill Daniels’ foundation which has had a tremendous impact on the region,” said Hanna Skandera. “I am committed to honoring Bill Daniels’ vision and direction for the foundation and upholding the importance of his values. I am thrilled to have the opportunity to build on and further his legacy and our impact.”

Skandera is a current member of the Daniels Fund board of directors and serves as CEO of Mile High Strategies. She also serves as Vice Chair of the Colorado Community College board as well as numerous other boards. Previously, she served as Secretary of Education for the State of New Mexico under Governor Susana Martinez, realizing the most significant gains for students in New Mexico’s recent history. In this role, she oversaw a budget of $2.7 billion and more than 300 employees. Skandera also served as Undersecretary for Governor Arnold Schwarzenegger, Deputy Commissioner for Governor Jeb Bush, and Deputy Chief of Staff and Senior Policy Advisor for U.S. Secretary of Education Margaret Spellings.

Jim Nicholson, chairman of the board of the Daniels Fund, stated enthusiastically, “After a competitive nationwide search, the Daniels Fund board is very pleased to welcome Hanna Skandera as our new President and CEO. Hanna’s impressive qualifications and background make her the ideal leader to advance Bill Daniels’ vision, and the Daniels Fund’s work of helping people to have a better life, whether as scholarship recipients or beneficiaries of our grants.”

The Daniels Fund was established by cable television pioneer Bill Daniels. It is a private charitable foundation dedicated to making life better for the people of Colorado, New Mexico, Utah, and Wyoming through its grants program, scholarship program, and ethics initiative. Since its founding in 2000, the Daniels Fund has granted nearly $1 billion to deserving organizations and scholars, while simultaneously growing the foundation’s endowment from $1 billion to more than $1.5 billion. Visit DanielsFund.org to learn more.

Attachments 



Bruce Wilmsen
Daniels Fund
720.941.4429
[email protected]

Posted on

Longtime Finance Leader and Life Sciences Executive Paul Parker Elected to Clorox Board

PR Newswire

OAKLAND, Calif., Nov. 18, 2020 /PRNewswire/ — The Clorox Company (NYSE:CLX) announced today that Paul Parker was formally elected to serve on its board of directors. Currently a corporate officer and senior vice president of strategy and corporate development for Thermo Fisher Scientific Inc., he has spent more than three decades within the financial services industry, with a focus on global mergers and acquisitions and investment banking.

“Paul’s deep experience in finance, M&A and strategy will contribute important perspective to the board going forward,” said Clorox lead independent director Pamela Thomas-Graham. “This expertise will be especially valuable as Clorox looks to build on its momentum and support its ambition of accelerating long-term growth.”

Paul’s deep experience in finance, M&A and strategy will contribute important perspective to the board going forward.

At Thermo Fisher, Parker, 57, is responsible for corporate strategy, mergers and acquisitions, corporate social responsibility, government relations, and digital marketing and e-commerce. He previously served as chairman of global M&A at Goldman Sachs & Co. and held senior finance leadership roles at Barclays and Lehman Brothers.

Additional information about The Clorox Company board of directors can be found at www.thecloroxcompany.com.

The Clorox Company

The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products; Pine-Sol® cleaners; Liquid-Plumr® clog removers; Poett® home care products; Fresh Step® cat litter; Glad® bags and wraps; Kingsford® charcoal; Hidden Valley® dressings and sauces; Brita® water-filtration products; Burt’s Bees® natural personal care products; and RenewLife®, Rainbow Light®, Natural Vitality Calm™, NeoCell® and Stop Aging Now® vitamins, minerals and supplements. The company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro™ and Clorox Healthcare® brand names. More than 80% of the company’s sales are generated from brands that hold the No. 1 or No. 2 market share positions in their categories.

Clorox is a signatory of the United Nations Global Compact and the Ellen MacArthur Foundation’s New Plastics Economy Global Commitment. The company has been broadly recognized for its corporate responsibility efforts, listed No. 1 on the 2020 Axios Harris Poll 100 reputation rankings and included on the Barron’s 2020 100 Most Sustainable Companies list and the Human Rights Campaign’s 2020 Corporate Equality Index, among others. In support of its communities, The Clorox Company and its foundations contributed more than $25 million in combined cash grants, product donations and cause marketing in fiscal year 2020. For more information, visit TheCloroxCompany.com, including the Good Growth blog, and follow the company on Twitter at @CloroxCo.

CLX-C

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/longtime-finance-leader-and-life-sciences-executive-paul-parker-elected-to-clorox-board-301176438.html

SOURCE The Clorox Company

Posted on

Home Federal Bancorp, Inc. of Louisiana Announces Approval of Stock Repurchase Program

SHREVEPORT, La., Nov. 18, 2020 (GLOBE NEWSWIRE) — Home Federal Bancorp, Inc. of Louisiana (the “Company”) (NASDAQ: HFBL), the holding company for Home Federal Bank, announced today that its Board of Directors at their meeting on November 18, 2020, approved the Company’s tenth stock repurchase program. The new repurchase program provides for the repurchase of up to 85,000 shares, or approximately 5.0% of the Company’s outstanding common stock from time to time, in open market or privately negotiated transactions. The stock repurchase program does not have an expiration date.

Home Federal Bancorp, Inc. of Louisiana is the holding company for Home Federal Bank which conducts business from its seven full-service banking offices and home office in northwest Louisiana. Additional information is available at www.hfbla.com.

Statements contained in this news release which are not historical facts may be forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. They often include words like “believe,” “expect,” “anticipate,” “estimate” and “intend” or future or conditional verbs such as “will,” “would,” “should,” “could” or “may.” We undertake no obligation to update any forward-looking statements.

Contact:
Home Federal Bancorp, Inc. of Louisiana
James R. Barlow, Chairman of the Board, President and Chief Executive Officer
(318) 222-1145



Posted on

Align Technology to Host Virtual Investor Day on November 23, 2020

SAN JOSE, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) — Align Technology, Inc. (Nasdaq: ALGN) today announced that it will host a virtual Investor Day on Monday, November 23, 2020, beginning at 8:00 a.m. Eastern time.

Meeting Schedule: The virtual meeting will take place between 8:00 a.m. – 1:00 p.m. Eastern time. Participants are advised to register in advance at: https://event.webcasts.com/starthere.jsp?ei=1398581&tp_key=8aa7c31f94

Location
: The event will be broadcast live on Align’s website at http://investor.aligntech.com/events. A replay of the webcast will be available after the meeting on Align’s website and will remain on the website for approximately three months following the event.

If you have any questions, please contact Courtney Moore at [email protected] or call 408-470-1037.


About Align Technology, Inc.


Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, iTero® intraoral scanners and services, and CAD/CAM software. Align has helped treat over 8 million patients with the Invisalign system and is driving the evolution in digital dentistry with the iTero intraoral scanner and exocad® CAD/CAM software − modernizing today’s practices by enabling enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Investor Relations Contact Press Contact
Madelyn Homick Shannon Mangum Henderson
Align Technology, Inc. Ethos Communication, Inc.
(408) 470-1180 (678) 261-7803
[email protected] [email protected]